2023
DOI: 10.1016/j.taap.2023.116634
|View full text |Cite
|
Sign up to set email alerts
|

Novel phenoxyacetylthiosemicarbazide derivatives as novel ligands in cancer diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(7 citation statements)
references
References 57 publications
0
0
0
Order By: Relevance
“…Compounds 1-18 were obtained in the reaction of phenoxyacetic acid hydrazide with the appropriate isothiocyanate at the boiling point of MeOH. The anticancer potential of the compounds against prostate and melanoma human cancer cells has been proved [31].…”
Section: Set Of Analyzed Compoundsmentioning
confidence: 99%
See 4 more Smart Citations
“…Compounds 1-18 were obtained in the reaction of phenoxyacetic acid hydrazide with the appropriate isothiocyanate at the boiling point of MeOH. The anticancer potential of the compounds against prostate and melanoma human cancer cells has been proved [31].…”
Section: Set Of Analyzed Compoundsmentioning
confidence: 99%
“…Molecules 2023, 28, x FOR PEER REVIEW 3 of 14 % plasma-protein binding (% PPB) of these compounds. Thiosemicarbazides are described as anticancer agents [28][29][30][31]. Some of them target topoisomerase II alpha and indoleamine-2,3-dioxygenase 1 (IDO 1) [29], others induce apoptosis in cancer cells via JNK signaling in human breast cancer cells [30].…”
Section: Set Of Analyzed Compoundsmentioning
confidence: 99%
See 3 more Smart Citations